Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy
Clinical trial NCT03223662 · TERMINATED
Trial details
- NCT number
- NCT03223662
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-31
- Primary completion
- 2018-07-27
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.